Small molecules that induce or stabilize the association of macromolecules
have proven to be useful effecters of a wide variety of biological processe
s. To date, all examples of such chemical inducers of dimerization have inv
olved known ligands to well-characterized proteins. The generality of this
approach could be broadened by enabling the discovery of heterodimerizers t
hat target known macromolecules having no established ligand, or heterodime
rizers that produce a novel biologic response in screens having no predeter
mined macromolecular target. Toward this end, we report the construction of
a diversified library of synthetic heterodimerizers consisting of an invar
iant ligand that targets the FK506-binding protein (AP1867) attached to 320
substituted tetrahydrooxazepines (THOXs). The THOX components were generat
ed by a combination of liquid- and solid-phase procedures employing sequent
ial Mitsonobu displacements to join two structurally diversified olefin-con
taining monomers, followed by ruthenium-mediated olefin metathesis to effec
t closure of the seven-membered ring. The 320 resin-bound THOX ligands were
coupled in parallel to AP1867, and the products were released from the res
in to yield candidate heterodimerizers in sufficient yield and purity to be
used directly in biologic testing. A representative panel of 25 candidate
heterodimerizers were tested for their ability to pass through the membrane
of human fibrosarcoma cells, and all were found to possess activity in thi
s tissue culture system. These studies pave the way for further studies aim
ed at using small-molecule inducers of heterodimerization to effect novel b
iological responses in intact cells.